Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
64.4M
-
Number of holders
-
164
-
Total 13F shares, excl. options
-
64.5M
-
Shares change
-
-375K
-
Total reported value, excl. options
-
$1.21B
-
Value change
-
-$5.27M
-
Put/Call ratio
-
1.43
-
Number of buys
-
81
-
Number of sells
-
-75
-
Price
-
$18.76
Significant Holders of AVID BIOSERVICES, INC. - Common Stock, par value $0.001 per share (CDMO) as of Q1 2023
184 filings reported holding CDMO - AVID BIOSERVICES, INC. - Common Stock, par value $0.001 per share as of Q1 2023.
AVID BIOSERVICES, INC. - Common Stock, par value $0.001 per share (CDMO) has 164 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.5M shares
.
Largest 10 shareholders include BlackRock Inc. (9.71M shares), VANGUARD GROUP INC (4.39M shares), STATE STREET CORP (3.74M shares), T. Rowe Price Investment Management, Inc. (3.74M shares), AltraVue Capital, LLC (3.72M shares), JENNISON ASSOCIATES LLC (2.94M shares), GENEVA CAPITAL MANAGEMENT LLC (2.33M shares), Ranger Investment Management, L.P. (2.27M shares), FMR LLC (2.25M shares), and SNYDER CAPITAL MANAGEMENT L P (1.73M shares).
This table shows the top 164 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.